Patent application number | Description | Published |
20110085936 | Methods and Apparatus for Reducing Count of Infectious Agents in Intravenous Access Systems - Methods and apparatus for preventing patient bloodstream infection by microorganisms during administration of various medications or fluids through IV lines. In particular, the invention reduces contamination of IV lines, connecters, stopcock valves, manifolds, ports, etc. by means of irradiation by violet and/or blue light. Each embodiment comprises a source of violet and/or blue light and an optical element optically coupled to that light source for shaping the radiation pattern of the light emitted by the light source. Preferably, a light-emitting diode or a laser diode that emits light in the desired wavelength can be used. The optical element, optically coupled to the light source, is embedded or installed in or attached to a component of an IV set, the emitted light being directed to a “point of entry” or any other stagnation point of an IV set. | 04-14-2011 |
20130303972 | METHODS AND APPARATUS FOR REDUCING COUNT OF INFECTIOUS AGENTS IN INTRAVENOUS ACCESS SYSTEM - The device disclosed herein may be affixed over a transparent dressing overlying the catheter entry point, or may be used independent of such a dressing. The device may be affixed to the catheter insertion site using an adhesive or fastening band, or through other methods. Depending on context, the device may be used continuously or periodically, and may be affixed such that it is directly abutting a transparent dressing or directly adjacent to the skin surface, or it may be spaced a certain distance from the skin. If spaced from the skin, light may be directed from the light sources, either directly or indirectly through optical conduits. Preferably the light sources will be positioned such that light from the light sources overlaps at one or more areas on the skin, especially the catheter entry point. | 11-14-2013 |
Patent application number | Description | Published |
20100247386 | PICO LITER WELL HOLDING DEVICE AND METHOD OF MAKING THE SAME - Described herein are embossing methods for forming pico liter well arrays (and other structures), arrangements of such pico liter well arrays, for example, in arrays of pico liter well areas, and methods of forming templates for such embossing. Also described as wells with a refractive index similar to that of an aqueous medium used for supporting cells in the wells. | 09-30-2010 |
20110014688 | PICO LITER WELL HOLDING DEVICE AND METHOD OF MAKING THE SAME - The present invention broadly comprises a holding device for studying cells comprising at least one cavity adapted to receive cells in a medium consisting essentially of water, the cavity having a substrate and a generally inert wall, wherein the substrate includes a surface for receiving the medium, and wherein the surface includes a multiplicity of pico liter wells and is characterized in that the substrate is substantially translucent and has a refractive index equal to the refractive index of the medium. The invention further comprises a method of making the holding device comprising providing a carrier plate, applying an adhesive layer to the carrier plate, depositing a curable substrate on the adhesive layer, applying a second layer of adhesive to the substrate, attaching a wall structure to the second layer of adhesive, forming a multiplicity of pico liter wells in the substrate, curing the substrate, and removing the template. | 01-20-2011 |
20110034348 | DEVICE FOR THE STUDY OF LIVING CELLS - A cell study device, comprising, a base layer, a planar conduit defining layer, including a conduit cut out of the layer; and a planar cover layer which defines a capillary flow channel in said conduit layer, said conduit layer and said cover layer acting as side walls for said capillary flow channel, wherein said layers are formed of materials that do not interfere with cell behavior over a period of at least 5 hours when loaded with aqueous solution. | 02-10-2011 |
20110036787 | PARTICLE SEPARATION - Apparatus for increasing a concentration of large particles in a mixture which includes the large particles and smaller particles, including a flow chamber, a filtrate accepting chamber, a filtering component separating the flow chamber from the filtrate accepting chamber, the filtering component including a plurality of pores passing therethrough, characterized by further including means for generating a flow of the fluid in the flow chamber, with a flow component in a direction parallel to a surface of the filtering component sufficient to substantially prevent particles from adhering to the filtering component and clogging the pores. A method of increasing a concentration of large particles in a mixture which includes the large particles and smaller particles, including providing a flow chamber and a filtrate accepting chamber separated by a filtering component, the filtering component including a plurality of pores passing therethrough, and placing a fluid with the mixture in the flow chamber, characterized by causing the fluid with the mixture to flow in the flow chamber, with a flow component parallel to a surface of the filtering component sufficient to substantially prevent particles from adhering to the filtering component and clogging the pores, thereby increasing the concentration of the larger particles relative to the concentration of the smaller particles in the mixture. Related apparatus and methods are also described. | 02-17-2011 |
Patent application number | Description | Published |
20110100373 | METHOD OF DETECTING ENDOTRACHEAL TUBE MISPLACEMENT - A method of intubating a subject is disclosed. The method comprises inserting an endotracheal tube into the tracheal airway of the subject; inflating a cuff associated with the endotracheal tube within the airway below the vocal cords; measuring a level of at least one measure being indicative of leakage of secretion past the cuff to the lungs; comparing the level of the measure with an optimal level of the measure; and adjusting inflation of the cuff based on the comparison so as to generally minimize leakage of secretion from above the cuff to the lungs, while minimizing pressure associated damages to the airway. The measure(s) can be carbon dioxide concentration, a proxy measure from which such concentration can be inferred, or the level of one or more additives delivered to a subject during intubation. | 05-05-2011 |
20110197888 | METHOD AND SYSTEM FOR VENTILATION - A method of monitoring tracheal pressure of a subject is disclosed. The subject is ventilated with breathing gas flowing via an endotracheal tube having an inflatable cuff. The method comprises monitoring sealing of the trachea by the cuff using a close loop control, varying a ventilation pressure thereby varying flow level of the breathing gas, monitoring a response pressure within the cuff in response to the variation, and calculating the tracheal pressure using the ventilation pressure variations, the cuff response pressure and the flow level. In some embodiments, an under-pressure is applied for suctioning fluid carrying secretions, synchronously with variations in the tracheal pressure. | 08-18-2011 |
20120090620 | DEVICE AND METHOD FOR IRRIGATING-EVACUATING A BODY CAVITY - A device for irrigating a body cavity is disclosed. The device comprises a first pump and a second pump being operatively linked via a manually-operated actuator member. The actuator member has at least a mode in which the actuator member activates the first pump to eject an initial volume of fluid out of the device, and a mode in which the actuator member activates the second pump to eject fluid out of the device and simultaneously activates the first pump to withdraw fluid into the device. | 04-19-2012 |
20140288408 | PRESSURE REGULATING SYRINGE AND METHOD THEREFOR - A pressure regulating syringe comprises a barrel assembly terminating with a tubular tip positionable in fluid communication with a fluid chamber, a plunger that is manually and axially displaceable within a barrel of the barrel assembly, a pressure sensor mounted onto the plunger adjacent to its distal end, for generating one or more electrical signals representative of a change in pressure within the fluid chamber, circuitry housed within the plunger for processing the generated signals, and a display mounted on the plunger for displaying an output indicative of the processed signals. The output is changeable upon axial displacement of the plunger when the tubular tip is positioned in fluid communication with the fluid chamber, which is for example a cuff surrounding a medical tube. Fluid is delivered by manually manipulating a fluid delivery element in response to the displayed output until a desired fluid delivery operation is performed. | 09-25-2014 |
20140366874 | SYSTEM AND METHOD FOR CONTROLLING AND MONITORING FLOW IN AN ENDOTRACHEAL TUBE - A system for controlling and monitoring flow in a cuffed endotracheal tube device is disclosed. The system comprises: a connector panel having at least three connectors adapted for establishing fluid communication with proximal ends of at least a first fluid line, a second fluid line and a cuff inflation line of the endotracheal tube device. The system can further comprise a processing unit and a control unit, wherein the processing unit is configured to instruct the control unit to execute various operations, including at least a rinsing procedure, a suctioning procedure, a cuff inflation procedure, a leak detection procedure and a venting procedure, and to select any of the first and the second fluid lines for any of the rinsing, suctioning, leak detection and venting procedures. In some embodiments, the system exploits the cuff as sensor to sense pulmonary data. | 12-18-2014 |
20150209532 | METHOD OF DETECTING ENDOTRACHEAL TUBE MISPLACEMENT - A method of intubating a subject is disclosed. The method comprises inserting an endotracheal tube into the tracheal airway of the subject; inflating a cuff associated with the endotracheal tube within the airway below the vocal cords; measuring a level of at least one measure being indicative of leakage of secretion past the cuff to the lungs; comparing the level of the measure with an optimal level of the measure; and adjusting inflation of the cuff based on the comparison so as to generally minimize leakage of secretion from above the cuff to the lungs, while minimizing pressure associated damages to the airway. The measure(s) can be carbon dioxide concentration, a proxy measure from which such concentration can be inferred, or the level of one or more additives delivered to a subject during intubation. | 07-30-2015 |
Patent application number | Description | Published |
20090064349 | Chimeric Avian-Based Screening System Containing Mammalian Grafts - The present invention relates to animal model systems comprising a chimera between an avian embryo and a mammalian organism. Specifically, chimeric model systems comprising normal, diseased or genetically transformed mammalian cells and tissues transplanted into avian embryos, and uses thereof for in vivo testing of drugs and therapeutic modalities are disclosed. | 03-05-2009 |
20110039791 | ACETYLCHOLINESTERASE (ACHE)-DERIVED PEPTIDE AS AN INDUCER OF GRANULOCYTOPOIESIS, USES AND METHODS THEREOF - The present invention describes the use of an AChE-R-derived peptide, also known as ARP, as an inducer of hemopoietic cell differentiation and expansion, specifically for the granulocytic population. In addition, the use of ARP as an inducer of thrombopoietin and pro-inflammatory cytokines is also presented. ARP may further be used in the pre-transplant priming of hematopoietic stem cells. Other uses and methods utilizing ARP are also described herein. | 02-17-2011 |
20130171680 | CHIMERIC AVIAN-BASED SCREENING SYSTEM CONTAINING MAMMALIAN GRAFTS - The present invention relates to animal model systems comprising a chimera between an avian embryo and a mammalian organism. Specifically, chimeric model systems comprising normal, diseased or genetically transformed mammalian cells and tissues transplanted into avian embryos, and uses thereof for in vivo testing of drugs and therapeutic modalities are disclosed. | 07-04-2013 |